Iran Could Open Strait of Hormuz Without Conditions as Part of Peace Deal Petraeus Indicates Healthcare and Tech Boost SP 500 to Fresh Highs Communication Services Slips US Private Payrolls Rise 109000 in April Exceeding Expectations ADP Report Zydus Lifesciences Revises Share Buyback Price Increased to Rs 1260 Repurchase Size Reduced Dow Jones Leads Flat Market Session Iren Credo Technology Vertiv Draw Attention Qualcomm Stock Surges as Investors Eye AI Device Boom FBRX Q1 2026 Earnings PreRevenue Biotech Reports Narrow EPS Miss Amid Ongoing Development NXE Q1 2026 Earnings Heavy Losses No Revenue but Stock Edges Higher BBDC Q1 2026 Earnings EPS Falls Short as Stock Rises ALBT Q1 2026 Earnings Narrowed Losses Maintain Focus on Cell Therapy Pipeline FCAP Q1 2026 Earnings Solid EPS of 130 Drives Modest Stock Gain TULP Q4 2014 Earnings EPS Misses Estimates Significantly ZoomInfo Technologies GTM Declines 3 as Stock Tests Key Support Levels Beazer Homes BZH Sees Uptick as Market Tests Key Resistance Near 2558 Korro Bio Inc KRRO Surges 62 as Biotech Stock Tests Key Resistance at 1295 DexCom DXCM Rallies 326 Testing Resistance After Support Hold Red Cat Holdings RCAT Jumps 421 as Drone Maker Breaks Past Key Support ERII Q1 2026 Earnings EPS Miss Highlights Ongoing Cost Pressures Despite Stock Gain Deutsche Bank DB Q1 2026 Earnings Modest EPS Beat Amidst Challenging Banking Environment Novagold Resources NG Q1 2026 Earnings Narrower Loss Drives 74 Stock Gain MGY Q1 2026 Earnings Modest EPS Beat as Operational Discipline Continues CSX Q1 2026 Earnings EPS Beats Estimates by 925 as Stock Slips Lisata Therapeutics Q3 2025 Earnings NarrowerthanExpected Loss as Biotech Advances Clinical Pipeline IHI Achieves Milestone with First Satellite Imagery from Observation Spacecraft GPCR Q1 2026 Earnings EPS Beat Drives Modest Stock Gain as PreRevenue Biotech Advances Pipeline Bluelinx Holdings BXC Gains Ground Testing Key Resistance at 5222 MCRI Q1 2026 Earnings EPS Surges Past Estimates with 349 Beat SEAT Q1 2026 Earnings EPS Misses Estimates as Loss Widens More Than Expected EH Q4 2025 Earnings Massive EPS Surprise as Profitability Arrives ULCC Q1 2026 Earnings WiderThanExpected Loss Narrows Shares Surge 7 FVCB Q1 2026 Earnings Earnings Beat Amid Modest Stock Decline Supernus Pharmaceuticals SUPN Q1 2026 Earnings Robust EPS Beat Overshadowed by Mild Share Decline PFS Q1 2026 Earnings Strong Earnings Beat Amidst Stable Operations